Balance

15 drugs in development·5 companies·1 clinical trial

Drug Pipeline by Phase

Approved(1)

Drug	Company
ceftriaxone	Teva Pharmaceutical Industries Limited (TEVA)

Phase 3(8)

Drug	Company
hmpl-306	HUTCHMED (China) Limited (HCM)
hmpl-306 regimen	HUTCHMED (China) Limited (HCM)
hmpl-453	HUTCHMED (China) Ltd (HMDCF)
hmpl-506	HUTCHMED (China) Limited (HCM)
hmpl-523	HUTCHMED (China) Limited (HCM)
hmpl-689	HUTCHMED (China) Limited (HCM)
hmpl-a580	HUTCHMED (China) Limited (HCM)
hmpl-a83	HUTCHMED (China) Limited (HCM)

Phase 2(1)

Drug	Company
cgf166	GENVEC INC (GNVC)

Phase 1(4)

Drug	Company
100 µci [14c] hmpl-306	HUTCHMED (China) Limited (HCM)
100 µci [14c] hmpl-306	HUTCHMED (China) Ltd (HMDCF)
hmpl-453	HUTCHMED (China) Limited (HCM)
hmpl-453	HUTCHMED (China) Limited (HCM)

Preclinical(1)

Drug	Company
x.msc	VITASPRING BIOMEDICAL CO. LTD. (NONE)

Compare drugs

ceftriaxone vs hmpl-306 ceftriaxone vs hmpl-306 regimen ceftriaxone vs hmpl-453

Frequently asked questions

How many drugs are in development for Balance?

BioSniper tracks 15 drugs in development for Balance across 5 companies.

How many clinical trials target Balance?

There are 1 clinical trial targeting Balance tracked by BioSniper.

Deep-dive into Balance

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis

Balance — Drugs in Development & Clinical Trials | BioSniper